"A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-1 and BR1015-2 Under Fed Conditions in Healthy Volunteers"

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 4, 2023

Primary Completion Date

October 3, 2023

Study Completion Date

October 3, 2023

Conditions

Hypertension

Interventions

DRUG

BR1015

One tablet administered alone

DRUG

BR1015-1

One tablet administered alone

DRUG

BR1015-2

One tablet administered alone

Trial Locations (1)

Clinical Research Center, H PLUS Yangji Hospital, Seoul